Tomographic and histologic aspects in patients with pancreas exocrine neoplasm

Authors

Keywords:

pancreas, pancreatic exocrine tumor, computerized axial tomography, cancer staging, Imaging Service.

Abstract

Introduction: The pancreas cancer originates in the pancreatic gland and it is one of the more invasive neoplasms due to its quick dissemination, lack of specific symptoms in its beginnings and its late diagnosis.

Objective: To characterize patients with pancreas cancer according to variables of interest.

Methods: An observational, descriptive and cross-sectional study was carried out in the Imaging Service of Saturnino Lora Teaching Provincial Clinical Surgical Hospital in Santiago de Cuba, from January, 2013 to December, 2017 to 70 patients with suggestive tomographic diagnosis of this malignancy.

Results: In the series the pancreatic exocrine tumor prevailed in patients older than 60 years (37.1 %), the male sex (54.2 %) and mixed race (61.4 %). The predominant histologic diagnosis was the ductal adenocarcinoma hardly differentiated (47.2 %), as long as, the risk factors mostly associated with the neoplasm were fatty foods (68.6 %), nicotine addiction (61.4 %) and alcoholism (50.0 %), and the most frequent personal pathological history was diabetes mellitus (37.1 %).

Conclusions: The computerized axial tomography provides a detailed description of the pancreatic neoplasms and their extension, which is very useful for the staging of these malignancies and, also, it determines the therapeutic behavior we should follow.

Downloads

Download data is not yet available.

References

1. Ladrón de Guevara D, Pavez G, Zapata J, Romero C, Tapia V, Buckel E, et al. Utilidad pronóstica del PET/CT en cáncer de páncreas. Rev Med Chile. 2018 [citado 22/01/2019];146(4):413-21. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000400413

2. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2016;63(5):318-48.

3. Tobias JS, Hochhauser D. Cancer and its management. 6 ed. Philadelphia: W.B. Saunders; 2009. p. 276-89.

4. Zhu D, Wang L, Zhang H, Chen J, Wang Y, Byanju S, et al. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma. A systematic review and meta-analysis. Medicine. 2017; 96(33):7813.

5. González Marcos A. Cáncer de páncreas, el más mortal y difícil de diagnosticar. Madrid: Agencia EFE; 2017 [actualizado 16 Nov 2017; citado 13/01/2018]. Disponible en: http://www.efesalud.com/cancer-depancreas-mortal

6. Hertogs Alciturri B. Diabetes en cáncer de páncreas: ¿Factor de riesgo o manifestación de la enfermedad? [tesis de grado]. Madrid: Universidad Complutense; 2017 [citado 13/01/2018]. Disponible en: http://147.96.70.122/Web/TFG/TFG/Memoria/BELEN%20HERTOGS%20ALCITURRI.pdf

7. Kasper D, Hauser S, Jameson JL. Harrison Principios de medicina Interna. 19 ed. New York: McGraw Hill; 2016.

8. Petersen GM. Familial pancreatic cancer: a review. Semin Oncol. 2016;43(5):548-53.

9. Noya Chaveco ME, Moya González NL, LLamos Sierra N, Morales Larramendi R, Cardona Garbey DL, Valle Díaz S del, et al. Cáncer de páncreas exocrino. En: Roca Goderich. Temas de medicina interna. 5 ed. T 2. La Habana: Editorial Ciencias Médicas; 2017. p. 271-5.

10. Robles G, Fastag D. Cáncer de páncreas: epidemiología y factores de riesgo. Rev Gastroenterol Mex. 2007;72(2):154-9.

11. Organización Panamericana de la Salud. Clasificación estadística internacional de enfermedades y problemas relacionados con la salud. 10 revisión. CIE-10-MC. Washington, DC: OPS; 2014.

12. American Cancer Society. Estadísticas importantes sobre el cáncer de páncreas. Atlanta: American Cancer Society; 2019 [citado 04/01/2020]. Disponible en: https://www.cancer.org/es/cancer/cancer-de-pancreas/acerca/estadisticas-clave.html

13. Cuba. Ministerio de Salud Pública; Dirección de Registros Médicos y Estadísticas de Salud. Anuario estadístico de salud. 2016. La Habana: MINSAP; 2017 [citado 04/01/2020]. Disponible en: https://files.sld.cu/dne/files/2017/05/Anuario_Estad%c3%adstico_de_Salud_e_2016_edici%c3%b3n_2017.pdf

14. Chan Núñez C, Ramírez del Val A. Cáncer de páncreas. Rev Gastroenterol Méx. 2011 [citado 29/01/2018];76(1). Disponible en: http://www.revistagastroenterologiamexico.org/es-avancesenfermedades-del-pancreas-articulo-X0375090611252860

15. Choe KA. Intraductal papillary mucinous tumors and mucinous cystic tumors of the pancreas: imaging. Part II. J Hepatobiliary Pancreat Surg. 2003 [citado 22/01/2019];10(2):137-41. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1007/s00534-002-0740-8

16. Sendra Gutiérrez JM, Palma Ruiz M, Sarría Santamera A, Puerto Vázquez M. Manejo hospitalario del cáncer de páncreas en España y estudio de los factores asociados a la mortalidad intrahospitalaria. Gastroenterol Hepatol. 2008;31(6):319-26.

17. American Society of Clinical Oncology. Cáncer de páncreas. Alexandria: ASCO; c2005-2018 [actualizado 5 May 2018; citado 22/01/2019] Disponible en: https://www.cancer.net/es/tipos-de-cancer/cancer-de-pancreas/

18. Laban Villanueva CE, Díaz Plasencia JA, Yan Quiroz EF, Guevara Arrascue JL. Tendencias en la incidencia y factores de riesgo asociados al desarrollo de cáncer de páncreas: Instituto Regional de Enfermedades Neoplásicas "Dr. Luis Pinillos Ganoza"-IREN Norte. 2008-2011. Rev Gastroenterol Perú. 2012;32(2):161-8.

19. López Serrano A. Factores de riesgo y diagnóstico temprano en cáncer de páncreas. Gastroenterol Hepatol. 2010;33(5):382-90.

20. Montejo Gañán LF, Ángel Ríos L, Sarría Octavio de Toledo ME, Martínez Mombila LH, Ros Mendoza LH. Estadificación mediante tomografía computarizada del carcinoma de páncreas. Radiología. 2018 [citado 07/11/2019];60(1):10-23. Disponible en: https://www.webcir.org/revistavirtual/articulos/2019/1_marzo/esp/estadificacion_esp.pdf

Downloads

Published

2020-07-15

How to Cite

1.
Dosouto Lemus V, Monteiro Soares M do R, Lemus Dosouto Y, Flores Ramírez I, García Fajardo JD. Tomographic and histologic aspects in patients with pancreas exocrine neoplasm. MEDISAN [Internet]. 2020 Jul. 15 [cited 2025 Jun. 15];24(4):610-26. Available from: https://medisan.sld.cu/index.php/san/article/view/2866

Issue

Vol. 24 No. 4 (2020): JULIO-AGOSTO

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.